Use when the user asks to "build a story bank", "collect our origin and customer stories", or "assemble reusable proof stories for the message"; assembles reusable narrative units — origin, founder, customer, transformation, and proof stories — each tagged to a claims-ledger ID and a message-house pillar, with every proof labeled Measured / User-provided / [needs source]. Not for authoring the message house or pillars — use message-system-architect; not for brand voice or naming rules — use brand-language-codifier; not for finished long-form prose — use content-writer; not for adjudicating whether a proof is true — use offer-claims-registry. 品牌故事库/起源客户转化/证据故事单元
日本語の概要は準備中です。原文の説明を表示しています。
unempyd/revenueos☆ 72026年9月14日 更新
Use when the user asks to "make everyone tell the same story", "write our elevator pitch ladder", or "build a spokesperson Q&A and approved boilerplate pack"; derives from the narrative-registry canon, message house, and brand voice a repeatable enablement kit — an elevator ladder (10-second / 30-second / 2-minute), a spokesperson Q&A (tough questions with on-canon answers), an approved boilerplate/bio pack (25 / 50 / 100-word), and a do/don't language sheet — so sales, support, founders, and partners repeat one consistent story. Not for the launch-day runbook — use launch-day-conductor; not for finished per-channel copy — use content-writer or each discipline creative builder; not for launch-window battle cards — use sales-enablement-kit; this kit never adjudicates a claim. 叙事赋能包/电梯梯度/发言人问答/审定样板/该说不该说
日本語の概要は準備中です。原文の説明を表示しています。
unempyd/revenueos☆ 72026年9月14日 更新
Use when the user asks to "design an employee advocacy program", "set up founder-led sharing", or "build a share kit for the team"; produces an advocacy program blueprint in two modes — participation-driven opt-in (default) or top-down assigned with its coercion and authenticity risks flagged — with a voluntary opt-in roster spec submitted as channel-registry proposal events, share kits with mandatory per-person variation, staggered human posting windows plus anti-pod guardrails (no coordinated identical reshares, no engagement rings), per-person material-connection disclosure lines per FTC and 《互联网广告管理办法》, and a Slack/Teams distribution spec. Not for paid creator campaigns — use campaign-planner. 员工倡导/创始人IP分享/内部分享计划/披露合规
日本語の概要は準備中です。原文の説明を表示しています。
unempyd/revenueos☆ 72026年9月14日 更新
Use taste as a competitive moat and business advantage. In the AI and vibe-coding era, execution is commoditized. Taste is the defensible edge. Use when advising founders on product differentiation, building product culture, evaluating why some products win despite fewer features, or understanding taste as a strategic asset.
日本語の概要は準備中です。原文の説明を表示しています。
Dragoon0x/taste-skills☆ 62026年2月27日 更新
When the user wants to plan, evaluate, or build a free tool for marketing purposes — lead generation, SEO value, or brand awareness. Also use when the user mentions "engineering as marketing," "free tool," "marketing tool," "calculator," "generator," "interactive tool," "lead gen tool," "build a tool for leads," or "free resource." This skill bridges engineering and marketing — useful for founders and technical marketers.
日本語の概要は準備中です。原文の説明を表示しています。
AxelMrak/ai☆ 52026年2月20日 更新
Structured validation framework that scores product ideas. Use when evaluating problem severity, willingness-to-pay, or founder-market fit. For market intelligence, see market-research.
日本語の概要は準備中です。原文の説明を表示しています。
tuliosousapro/SaaS-blueprint☆ 52026年8月31日 更新
10 C-level advisory agent skills and plugins for Claude Code, Codex, Gemini CLI, Cursor, OpenClaw. CEO, CTO, COO, CPO, CMO, CFO, CRO, CISO, CHRO, Executive Mentor. Multi-role board meetings, strategy routing, structured recommendations. For founders needing executive-level decision support.
日本語の概要は準備中です。原文の説明を表示しています。
micsapp/micstec-skills☆ 42026年3月20日 更新
Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.
日本語の概要は準備中です。原文の説明を表示しています。
huang-sh/DeepScience☆ 42026年7月15日 更新
End-to-end observational epidemiology analysis — from research question (PECO Population/Exposure/Comparator/Outcome) to publication-ready statistical report. Covers cohort/case-control/cross-sectional design, regression with confounders, propensity scoring, sensitivity analysis. Writes Python code for every step. Use for epidemiology study analysis, NHANES/UK-Biobank-style analyses.
日本語の概要は準備中です。原文の説明を表示しています。
huang-sh/DeepScience☆ 42026年7月15日 更新
When the user wants to plan, evaluate, or build a free tool for marketing purposes — lead generation, SEO value, or brand awareness. Also use when the user mentions "engineering as marketing," "free tool," "marketing tool," "calculator," "generator," "interactive tool," "lead gen tool," "build a tool for leads," or "free resource." This skill bridges engineering and marketing — useful for founders and technical marketers.
日本語の概要は準備中です。原文の説明を表示しています。
gracefullight/pkgs☆ 42026年10月2日 更新
Protect your SaaS app from common vulnerabilities. Use when building auth, handling user data, or deploying features. Covers authentication, data protection, API security, and OWASP Top 10 for non-technical founders using AI tools.
日本語の概要は準備中です。原文の説明を表示しています。
aibot88/sec_skill_store☆ 42026年5月27日 更新
Background information about Lendtrain powered by Atlantic Home Mortgage — company history, credentials, founder bio, and contact information for borrower trust-building.
日本語の概要は準備中です。原文の説明を表示しています。
aibot88/sec_skill_store☆ 42026年5月27日 更新
Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.
日本語の概要は準備中です。原文の説明を表示しています。
peacezha/TRACE☆ 32026年10月11日 更新
Identify differentially bound regions across CLIP-seq conditions (knockdown vs control, treatment vs vehicle, disease vs healthy) using DEWSeq (sliding-window DESeq2), Flipper (Skipper-downstream), ASpeak, edgeR, or limma-voom. Use when computing condition-level changes in RBP binding intensity, choosing peak-level vs window-level vs crosslink-level testing, designing replicate experiments, or distinguishing biological binding shifts from technical confounders.
日本語の概要は準備中です。原文の説明を表示しています。
peacezha/TRACE☆ 32026年10月11日 更新
Detect and adjust for horizontal pleiotropy in two-sample Mendelian randomization by distinguishing uncorrelated (UHP) from correlated (CHP) pleiotropy and choosing among Egger, MR-PRESSO, MR-RAPS, CAUSE, LHC-MR, LCV, MR-Clust, MR-Mix, and contamination-mixture methods. Use when validating an MR causal claim, running the STROBE-MR sensitivity battery, suspecting a shared heritable confounder, working under weak-instrument or polygenic-exposure regimes, or reconciling discordant estimates across robust methods.
日本語の概要は準備中です。原文の説明を表示しています。
peacezha/TRACE☆ 32026年10月11日 更新
CEO/founder-mode plan review. Rethink the problem, find the 10-star product, challenge premises, expand scope when it creates a better product. Four modes: SCOPE EXPANSION (dream big), SELECTIVE EXPANSION (hold scope + cherry-pick expansions), HOLD SCOPE (maximum rigor), SCOPE REDUCTION (strip to essentials). Use when asked to "think bigger", "expand scope", "strategy review", "rethink this", or "is this ambitious enough". Proactively suggest when the user is questioning scope or ambition of a plan, or when the plan feels like it could be thinking bigger. (gstack)
日本語の概要は準備中です。原文の説明を表示しています。
mostafasudo/appilot☆ 32026年9月14日 更新
Score an unbuilt business idea on desirability, viability, feasibility, distribution wedge, why-now, founder-market-fit, market size, alternatives, defensibility, capital intensity, and regulatory/ethical risk — and return a GO / ITERATE / KILL verdict with kill criteria and a next kill test. Load when the user asks to evaluate a business idea, score a startup idea, screen an idea, decide whether to pursue this venture, do an idea review, or says "is this a good business idea", "should I build this", "evaluate this startup", "screen this idea", "go/no-go on this idea", "kill or pursue". Sub-skill of `venture-exploration`. Calls `fermi` for sizing, `assumption-mapping` for hidden beliefs, optional `pre-mortem` / `adversarial-hat` for high-stakes ideas. Does NOT evaluate built products — for that use `reality-check`.
日本語の概要は準備中です。原文の説明を表示しています。
dvy1987/agent-loom☆ 32026年8月8日 更新
Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.
日本語の概要は準備中です。原文の説明を表示しています。
peacezha/HPClaw☆ 32026年10月11日 更新
Identify differentially bound regions across CLIP-seq conditions (knockdown vs control, treatment vs vehicle, disease vs healthy) using DEWSeq (sliding-window DESeq2), Flipper (Skipper-downstream), ASpeak, edgeR, or limma-voom. Use when computing condition-level changes in RBP binding intensity, choosing peak-level vs window-level vs crosslink-level testing, designing replicate experiments, or distinguishing biological binding shifts from technical confounders.
日本語の概要は準備中です。原文の説明を表示しています。
peacezha/HPClaw☆ 32026年10月11日 更新
Detect and adjust for horizontal pleiotropy in two-sample Mendelian randomization by distinguishing uncorrelated (UHP) from correlated (CHP) pleiotropy and choosing among Egger, MR-PRESSO, MR-RAPS, CAUSE, LHC-MR, LCV, MR-Clust, MR-Mix, and contamination-mixture methods. Use when validating an MR causal claim, running the STROBE-MR sensitivity battery, suspecting a shared heritable confounder, working under weak-instrument or polygenic-exposure regimes, or reconciling discordant estimates across robust methods.
日本語の概要は準備中です。原文の説明を表示しています。
peacezha/HPClaw☆ 32026年10月11日 更新
Research venture capital firms, angel investors, and funding sources for startup fundraising. Use when: "投资人调研", "找VC", "research investors", "VC list", "funding sources", "investor database", "天使投资人", "venture capital", "融资对象", "投资人画像". Generates a structured investor research report with firm profiles, investment thesis, portfolio companies, contact strategies, and warm introduction paths. Part of UniqueClub founder toolkit. Learn more: https://uniqueclub.ai Pairs with pitch-deck-creator for complete fundraising preparation.
日本語の概要は準備中です。原文の説明を表示しています。
aAAaqwq/openclaw-team☆ 22026年6月18日 更新
Guide a startup to set a single quantified traction goal and define the critical path of milestones to reach it. Use whenever a founder needs to prioritize activities, set growth goals, define milestones, decide what NOT to work on, plan quarterly/yearly execution, cascade goals to teams, escape the 'too many things to do' trap, or apply a binary on-path/off-path filter to proposed work. Activates on phrases like 'traction goal', 'critical path', 'what should we focus on', 'too many priorities', 'prioritization', 'milestones', 'quarterly planning', 'yearly goals', 'OKRs', 'where should I spend my time', 'what NOT to do', 'company planning', 'goal setting', 'DuckDuckGo', 'roadmap'.
日本語の概要は準備中です。原文の説明を表示しています。
aAAaqwq/openclaw-team☆ 22026年6月18日 更新
Maxim cinematic brand film — engineered for commitment and emotional brand alignment. Uses Hero's Journey + Peak-End Rule + Emotional Arc Theory to convert viewers into brand advocates. Use for brand films, anthem ads, founder stories, long-form brand content. Triggers on cinematic, film, brand film, anthem, dramatic, epic, Hollywood-style.
日本語の概要は準備中です。原文の説明を表示しています。
DrNabeelKhan/maxim☆ 22026年9月17日 更新
Maxim L2 pack. Bundles: L1.1 AI Governance + L1.2 MemPalace Pro + L1.3 Proactive Watch. Primary framework: Fogg Behavior Model.
日本語の概要は準備中です。原文の説明を表示しています。
DrNabeelKhan/maxim☆ 22026年9月17日 更新